BECOME MEMBER SUPPORT
Year Cancer type Speaker
New Paradigms In The Management of Lung Cancer - 01 Sep 2022
Biomarker Driven Strategies in The Management of NSCLC
Case Based Panel Discussion | Managing a metastatic EGFRm NSCLC
Real World Evidence Osimertininb as SoC in the management of EGFRm NSCLC